Comparability of frame systems for the implantation of DBS electrodes in Parkinson’s disease
Objective: To compare the accuracy and precision of two different stereotactic frame and microdrive systems (i.e., Cosman-Roberts-Wells (CRW) replaced due to limited customer support and…Deep brain stimulation improves gait velocity acutely in patients with Parkinson’s disease
Objective: To systematically investigate the acute (5 minutes) and chronic (1 month) effects of deep brain stimulation (DBS) of subthalamic nucleus (STN) and globus pallidus…A Review of Electronic Devices to Track Medication Adherence in Parkinson’s Disease
Objective: The current study set out to compare existing electronic devices (EDs) for tracking medication adherence (MA) and to provide a framework for device selection…Closing the gap: How to record valuable data for movement disorders using FHIR
Objective: To make data generated in routine clinical practice in the treatment of patients with movement disorders and deep brain stimulation available for clinical decision-making…Efficacy of the ankle bracelet-laser to improve gait in Parkinson disease (PD).
Objective: To assess the efficacy of the ankle bracelet-laser in improving gait parameters and functional performance in Parkinson patients with freezing of gait (FOG) Background:…The Association Between Tic Disorders and Atopy
Objective: To determine whether pediatric patients with tic disorders have an altered risk of atopy when compared with controls, whether this difference in risk is…INTERMUSCULAR COHERENCE WITHIN THE UPPER LIMB IN PERSONS WITH ESSENTIAL TREMOR
Objective: The purpose of this research is to quantify the amount of tremorogenic activity shared between muscles of the upper limb in patients with Essential…A phase 2b randomized, double-blind, placebo-controlled study of suvecaltamide in the treatment of adults with moderate to severe essential tremor: study design and methodology
Objective: Evaluate the efficacy and safety of JZP385 (formerly CX-8998), a highly selective T-type calcium channel modulator, for symptomatic control of moderate to severe essential…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.